RaQualia Pharma Inc. (TYO:4579)
1,003.00
+3.00 (0.30%)
At close: Feb 6, 2026
RaQualia Pharma Employees
RaQualia Pharma had 64 employees as of December 31, 2024. The number of employees decreased by 3 or -4.48% compared to the previous year.
Employees
64
Change
-3
Growth
-4.48%
Revenue / Employee
47.64M JPY
Profits / Employee
-11.31M JPY
Market Cap
26.09B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 64 | -3 | -4.48% |
| Dec 31, 2023 | 67 | 2 | 3.08% |
| Dec 31, 2022 | 65 | -2 | -2.99% |
| Dec 31, 2021 | 67 | -3 | -4.29% |
| Dec 31, 2020 | 70 | 2 | 2.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Japan Tissue Engineering | 204 |
| ReproCELL | 99 |
| Healios K.K. | 65 |
| Immuno-Biological Laboratories | 58 |
| AnGes | 55 |
| StemRIM | 45 |
| Oncolys BioPharma | 42 |
| Kidswell Bio | 37 |